Your browser doesn't support javascript.
loading
[Mycobacterium xenopi pulmonary disease:report of 3 cases and literature review].
Kong, Y Y; Jiang, G L; Huang, H R; Che, N Y; Duan, H F.
  • Kong YY; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China.
  • Jiang GL; Clinical Lab on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
  • Huang HR; Clinical Lab on Tuberculosis, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101149, China.
  • Che NY; Department of Pathology, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China.
  • Duan HF; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University, Beijing 101149, China.
Zhonghua Jie He He Hu Xi Za Zhi ; 44(5): 474-480, 2021 May 12.
Article en Zh | MEDLINE | ID: mdl-34865369
ABSTRACT

Objective:

To analyze the clinical manifestations, radiographic characteristics and prognosis of Mycobacterium xenopi pulmonary disease, in order to improve diagnosis and treatment of the disease.

Methods:

Using "Mycobacterium xenopi, pulmonary disease" as the search term, from February 15, 2007 to February 21, 2021, a total of 1 264 cases were retrieved in the PubMed database. In the Wanfang database, using "Mycobacterium xenopi, pulmonary disease" as the search term, from February 15, 2007 to February 21, 2021, no related document was retrieved. In the CNKI database, "Mycobacterium xenopi, pulmonary disease" was used as the search term, and one relevant case report was retrieved, but did not meet the diagnostic criteria of Mycobacterium xenopi pulmonary disease issued by American Thoracic Society in 2007. The 1 264 cases from the literature and 3 cases of our institution were used for review.

Results:

Our 3 cases were elderly males complaining of cough and expectoration, and had underlying lung diseases. The imaging examination showed cavitary lesions. All of them had positive sputum smear for acid-fast bacillus and negative Xpert MTB/RIF examination. Mycobacterium xenopi was isolated at least 2 times from sputum samples. Although prescribed with chemotherapy, case 1 and case 2 died 4 years and 2 years later, respectively, after the diagnosis. Case 3 got sputum conversion, symptom improvement and radiographic responses after 30-month chemotherapy.

Conclusions:

The clinical manifestations of Mycobacterium xenopi pulmonary disease are atypical. For patients with positive sputum smear for acid-fast bacillus and negative Xpert MTB/RIF examination and conventional mycobacterial culture, Mycobacterium xenopi pulmonary disease should be considered. The disease deserves further attention from clinicians due to poor prognosis.
Asunto(s)

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mycobacterium xenopi / Enfermedades Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: Zh Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Mycobacterium xenopi / Enfermedades Pulmonares Tipo de estudio: Prognostic_studies Límite: Aged / Humans / Male Idioma: Zh Año: 2021 Tipo del documento: Article